Oncology Nursing News Top Stories: May 2021

Each month, we take a look back at the most popular Oncology Nursing News® stories. Here are the top 5 stories from May 2021.

5. Next Up in SCLC: Immunotherapy Combinations

In this piece, we take a look at how new immunotherapy combinations are being explored to improve outcomes in the small cell lung cancer space.

4. FDA Approves Frontline Pembrolizumab for HER2+ Gastric, GEJ Cancer

In early May, the FDA granted an accelerated approval to pembrolizumab plus trastuzumab, fluoropyrimidine- and platinum-containing chemotherapy for the frontline treatment of patients with locally advanced unresectable or metastatic HER2-positive gastric or gastroesophageal junction adenocarcinoma.

3. Shorter Adjuvant Trastuzumab Has Long-Term Benefits for HER2+ Breast Cancer

A 9-week trastuzumab regimen may be favorable for patients with HER2-positive early breast cancer who have low and intermediate risk factors.

2. CAR T-Cell Therapy Ushers in New Era for Myeloma Treatment

Following the FDA approval of idecabtagene vicleucel (ide-cel; Abecma) for patients with relapsed/refractory multiple myeloma, experts in the field are starting to navigate a new era of myeloma treatment featuring BCMA-directed CAR T-cell products, said Nina Shah, MD.

1. Cancer, COVID-19, and Aging in LGBTQ+ Communities

The reasons for LGBTQ+ health care disparities are complex but unequivocal, founded in many socio-economic and cultural factors.

Thanks for reading!